OBJECTIVE - To test PSA mass density (PSAMD) as a predictor of total tumor volume (TTV) at radical prostatectomy (RP).
METHODS - We conducted a detailed pathologic analysis of 469 RP from men with NCCN low risk prostate cancer who had Gleason score 3+3=6 (Grading group 1) at RP.